Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06116435 · ClinicalTrials.gov registry record · NA
A Pilot Factorial Trial of an Integrated Lifestyle Intervention
A NA study of Overweight and Obesity and Physical Inactivity, sponsored by University of Colorado, Denver.
- Recruiting
- Registry status
- NA
- Development phase
- 64
- Enrollment target
- 1
- Study location
NCT06116435: Recruiting NA study of Overweight and Obesity and Physical Inactivity, sponsored by University of Colorado, Denver.
NCT06116435 is a NA study of Overweight and Obesity and Physical Inactivity that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 64 participants, below the 228-participant average among 115 other Overweight and Obesity trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06116435, a NA study of Overweight and Obesity and Physical Inactivity, is actively recruiting participants, sponsored by University of Colorado, Denver.
- RECRUITING
- Registry status
- NA
- Development phase
- 64 participants
- Enrollment target
- 1
- Study location
Study Summary
This study plans to learn more about the feasibility and acceptability of integrating the Move physical activity support program within an existing lifestyle intervention program.
Primary Outcome
Acceptability of the Move physical activity support program will be assessed with results of the semi-structured focus groups or interviews from the participant and provider perspectives.
Conditions Studied
Interventions
- BEHAVIORAL Prevent T2
- BEHAVIORAL Move group-based classes
- BEHAVIORAL Fitness Membership
- BEHAVIORAL Mental Imagery
- BEHAVIORAL Move 1:1 Support
Study Locations (1)
Colorado
- University of Colorado Anschutz Medical Campus - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2023-12-04 |
| Est. Completion | 2027-03 |
| Phase | NA |
What NCT06116435 shows while recruiting
NCT06116435 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 64 participants, a relatively small participant target, below the 228-participant average among 115 other Overweight and Obesity trials with a reported enrollment target (72% lower).
The record links to 2 conditions, with Overweight and Obesity appearing as the primary indexed condition, and to 5 interventions - of which Prevent T2 is the first listed.
NCT06116435 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT06116435 about?
NCT06116435 is a clinical study titled "A Pilot Factorial Trial of an Integrated Lifestyle Intervention". This study plans to learn more about the feasibility and acceptability of integrating the Move physical activity support program within an existing lifestyle intervention program.
What is the current status of trial NCT06116435?
This trial is currently recruiting. It is a NA study. The enrollment target is 64 participants. The study started on 2023-12-04. Estimated completion is 2027-03.
What conditions does trial NCT06116435 study?
This clinical trial studies the following conditions: Overweight and Obesity, Physical Inactivity.
What interventions are being tested in trial NCT06116435?
The interventions under investigation include: Prevent T2 (BEHAVIORAL), Move group-based classes (BEHAVIORAL), Fitness Membership (BEHAVIORAL), Mental Imagery (BEHAVIORAL), Move 1:1 Support (BEHAVIORAL).
Who is sponsoring clinical trial NCT06116435?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06116435 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Overweight and Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06116435's enrollment target sits among peer trials
64 77th of 115 higher than 38 of 115 other Overweight and Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Overweight and Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Dose Response Effects of Pecan Consumption
RECRUITING · NA
-
Cottonseed Oil Dose Response
RECRUITING · NA
-
Cooking Skills to Improve Long-Term Weight Loss in Young Adults With Intellectual Disabilities
RECRUITING · NA
-
Testing the Adipose Expandability Hypothesis in Vivo During Overfeeding
RECRUITING · NA
-
Cottonseed Oil Versus Matched PUFA Effects
RECRUITING · NA
-
Effects of Watermelon or Low-fat Cookie Consumption on Wellness
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01853631 · 64 participants · Phase 1
Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
- NCT03739502 · 64 participants · Phase 2
A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant
- NCT03739814 · 64 participants · Phase 2
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
- NCT03866408 · 64 participants · Early Phase 1
Insulin Regulation of Lipolysis and Lipolysis Proteins
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI